Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$202.79
+0.7%
$196.83
$153.58
$218.66
$357.99B0.615.28 million shs4.99 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$131.67
+4.0%
$129.71
$99.71
$141.23
$228.35B0.75.47 million shs8.44 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$228.76
+0.3%
$232.03
$218.75
$251.99
$65.68B0.351.54 million shs1.60 million shs
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$136.90
+2.2%
$128.16
$93.17
$139.95
$32.37B0.661.98 million shs2.75 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$163.22
+0.9%
$158.35
$140.68
$169.99
$389.72B0.477.08 million shs6.75 million shs
Medtronic plc stock logo
MDT
Medtronic
$89.00
+0.9%
$91.00
$75.96
$96.25
$114.14B0.86.12 million shs7.34 million shs
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
$592.55
+1.7%
$569.64
$499.47
$595.17
$63.63B1.06500,149 shs627,319 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$226.15
+0.6%
$266.26
$197.01
$397.72
$16.35B1.09639,867 shs562,146 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.02%-5.20%-1.40%+12.26%+12.26%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.79%-0.93%-6.20%+9.70%+13.40%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.00%-1.67%-1.06%-0.07%-5.78%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.79%+1.38%+5.09%+12.34%+19.97%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.31%-0.84%-1.32%+11.03%+3.76%
Medtronic plc stock logo
MDT
Medtronic
-0.37%-3.93%-2.33%+8.05%+5.32%
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
+0.63%+0.84%+1.06%+10.52%+5.10%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-0.44%-2.32%+1.61%-32.58%-42.09%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.5537 of 5 stars
2.53.03.33.93.62.51.3
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8566 of 5 stars
2.44.02.54.54.12.52.5
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.7617 of 5 stars
2.54.04.24.02.93.31.3
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.5439 of 5 stars
2.43.04.23.64.01.71.3
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.4329 of 5 stars
2.33.04.23.93.52.50.6
Medtronic plc stock logo
MDT
Medtronic
4.4539 of 5 stars
2.24.03.34.03.52.50.6
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
2.9888 of 5 stars
2.40.01.73.13.42.51.3
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.5854 of 5 stars
3.43.01.73.22.81.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.92
Moderate Buy$211.454.27% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.944.76% Upside
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
3.00
Buy$278.2921.65% Upside
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.71
Moderate Buy$139.361.79% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.334.97% Upside
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$96.077.95% Upside
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
2.77
Moderate Buy$629.186.18% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.86
Moderate Buy$332.5047.03% Upside

Current Analyst Ratings Breakdown

Latest ABT, ABBV, BDX, CAH, JNJ, MDT, ROP, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2025
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$685.00
3/18/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$275.00
3/17/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$210.00 ➝ $240.00
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
3/4/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$200.00 ➝ $223.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
3/4/2025
Medtronic plc stock logo
MDT
Medtronic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$92.00 ➝ $107.00
(Data available from 3/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B6.35$14.99 per share13.53$1.90 per share106.73
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.44$5.67 per share23.22$22.36 per share5.89
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.64B3.18$21.26 per share10.76$89.57 per share2.55
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$222.28B0.15$11.32 per share12.09($12.09) per share-11.32
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.43$13.41 per share12.17$29.69 per share5.50
Medtronic plc stock logo
MDT
Medtronic
$33.20B3.44$7.29 per share12.21$38.69 per share2.30
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
$7.04B9.04$26.62 per share22.26$175.96 per share3.37
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.65$10.01 per share22.60$37.10 per share6.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.4084.5014.511.627.59%296.28%12.65%4/25/2025 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.2122.982.5231.95%20.74%11.19%4/16/2025 (Estimated)
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$6.0238.0014.631.638.47%15.74%7.29%5/1/2025 (Estimated)
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$5.3625.5415.301.490.59%-59.57%4.17%5/1/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.5414.742.5618.20%34.24%13.63%4/15/2025 (Estimated)
Medtronic plc stock logo
MDT
Medtronic
$3.68B$3.2927.0515.272.2212.83%14.07%7.70%5/22/2025 (Estimated)
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
$1.55B$14.3441.3227.992.7722.01%10.79%6.45%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.6933.8028.776.7417.03%18.60%13.80%4/24/2025 (Estimated)

Latest ABT, ABBV, BDX, CAH, JNJ, MDT, ROP, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.30N/AN/AN/A$685.24 millionN/A
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
2/18/2025Q3 2025
Medtronic plc stock logo
MDT
Medtronic
$1.36$1.39+$0.03$1.01$8.33 billion$8.29 billion
2/13/2025Q4 2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.75$1.82+$0.07$1.78$739.59 million$748.80 million
2/5/2025Q1 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.00$3.43+$0.43$1.04$5.13 billionN/A
1/31/2025Q4 24
AbbVie Inc. stock logo
ABBV
AbbVie
$2.98$2.16-$0.82-$0.02$14.81 billionN/A
1/30/2025Q2 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.74$1.93+$0.19$1.65$53.90 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.23%+6.04%273.33%53 Years
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.79%N/A30.85%N/A
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.161.82%+5.00%69.10%53 Years
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.021.48%+1.00%37.69%28 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.04%+5.43%74.59%63 Years
Medtronic plc stock logo
MDT
Medtronic
$2.803.15%+4.14%85.11%48 Years
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
$3.300.56%+10.04%23.01%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.37%-4.48%12.56%N/A

Latest ABT, ABBV, BDX, CAH, JNJ, MDT, ROP, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.4%4/15/20254/15/20255/15/2025
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
2/20/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.41%4/30/20254/30/20255/7/2025
3/7/2025
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
quarterly$0.82500.56%4/4/20254/4/20254/22/2025
2/3/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50561.61%4/1/20254/1/20254/15/2025
3/6/2025
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.703%3/28/20253/28/20254/11/2025
1/28/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.041.67%3/10/20253/10/20253/31/2025
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
1/28/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.2%2/7/20252/7/20252/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
17.94
0.66
0.55
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.13
0.63
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
1.02
0.54
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
Medtronic plc stock logo
MDT
Medtronic
0.48
1.90
1.39
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
0.35
0.40
0.37
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.79
2.23
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.76 billionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000287.14 million286.10 millionOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
46,500241.57 million241.35 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Roper Technologies, Inc. stock logo
ROP
Roper Technologies
15,800107.39 million106.30 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,70072.29 million71.92 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$202.79 +1.49 (+0.74%)
Closing price 03:59 PM Eastern
Extended Trading
$203.12 +0.34 (+0.17%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$131.67 +5.06 (+3.99%)
Closing price 03:59 PM Eastern
Extended Trading
$131.75 +0.08 (+0.06%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$228.76 +0.76 (+0.33%)
Closing price 03:59 PM Eastern
Extended Trading
$228.62 -0.14 (-0.06%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Cardinal Health stock logo

Cardinal Health NYSE:CAH

$136.90 +2.92 (+2.18%)
Closing price 03:59 PM Eastern
Extended Trading
$139.81 +2.91 (+2.12%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$163.22 +1.50 (+0.93%)
Closing price 03:59 PM Eastern
Extended Trading
$162.93 -0.29 (-0.18%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Medtronic stock logo

Medtronic NYSE:MDT

$89.00 +0.77 (+0.87%)
Closing price 03:59 PM Eastern
Extended Trading
$88.63 -0.37 (-0.41%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Roper Technologies stock logo

Roper Technologies NYSE:ROP

$592.55 +9.84 (+1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$592.45 -0.10 (-0.02%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Roper Technologies, Inc. designs and develops software, and technology enabled products and solutions. It operates through three segments: Application Software, Network Software, and Technology Enabled Products. The Application Software segment offers management, campus solutions, diagnostic and laboratory information management, enterprise software and information solutions, transportation management, financial and compliance management, and cloud-based financial analytics and performance management software; cloud-based software to the property and casualty insurance industry; and software, services, and technologies for foodservice operations. The Network Software segment provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; cloud-based software for the life insurance and financial services industries; supply chain software; health care service and software; data analytics and information; and pharmacy software solutions. The Technology Enabled Products segment offers ultrasound accessories; dispensers and metering pumps; wireless sensor network and solutions automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; RFID card readers; and medical devices. It distributes and sells its products through direct sales, manufacturers' representatives, resellers, and distributors. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$226.15 +1.24 (+0.55%)
Closing price 03:59 PM Eastern
Extended Trading
$223.10 -3.04 (-1.35%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.